One of the most important cytokines implicated in the progression of chronic heart failure is TNF-alpha.20 Although treatment with anti-TNF-alpha agents represents a major advance in the treatment of rheumatic disease, its impact on cardiovascular risk, especially in RA patients with preserved LV function (EF ≥ 50), remains controversial. This evidence concerns the gene TNF and rheumatoid arthritis.